Eledon rises on new mid-stage trial data, FDA fast track status for lead drug
We haven't written up this one. Seeking Alpha News has the full story — the link below goes straight to it.
More in Health & Medicine
Obamacare crackdown: Why Trump administration is removing 750,000 people from health insurance rolls
The Trump administration plans to remove hundreds of thousands of people from Obamacare rolls over alleged improper enrollment, while suspending brokers.
Syngene Expands Integrated Drug Development and Manufacturing Services with BMS
The collaboration between Syngene and Bristol Myers Squibb began in 1998, culminating in the establishment of the Biocon Bristol Myers Squibb Research and Development Center, Syngene's first dedicated…
Vertex aims for broad kidney disease label ahead of key readout next year
Vertex Pharmaceuticals reported that an experimental kidney disease drug called inaxaplin improved measures on a urine test in two different patient populations, raising optimism ahead of the…
Opinion: Former FDA commissioners: Heidi Overton has an opportunity to strengthen the FDA
Two former FDA commissioners: Heidi Overton is the right pick in a difficult moment.
Novo's CEO knows the drugmaker needs to build confidence
LONDON — Many investors were underwhelmed by Novo’s articulation of its strategy at the company’s capital markets day on Monday, and Mike Doustdar knows it. “In some ways, it's good that it's out ...
Panvel Municipal Corporation To Open Free 50-Bed Dialysis Centres In Kharghar, New Panvel With 200-Patient Daily Capacity
Panvel, September 22, 2026: Work on two 25-bed free dialysis centres in Kharghar and New Panvel, which are expected to provide dialysis to up to 200 patients a day, was reviewed by Panvel Municipal…